November 28, 2025November 28, 2025 Shares of Zydus Lifesciences Ltd are trading flat after hitting a day’s high of Rs 947.95 on 28th November, despite the firm announced on Thursday (27th November) that it has received tentative approval from the United States Food and Drug Administration (FDA) for empagliflozin…
November 10, 2025November 10, 2025 Shares of Zydus Lifesciences Ltd rose 1% to touch a day’s high of Rs 973 on 10th November, after the company announced on Friday, 7th November, that it had received tentative approval from the United States Food and Drug Administration (USFDA) for Olaparib Tablets,…
November 5, 2025November 5, 2025 Zydus Lifesciences has added another regulatory milestone to its record, securing a clean USFDA report for its Ahmedabad SEZ-II facility. The development comes just days before the company’s board meets to consider a Rs 5,000 crore fundraising plan. The USFDA…
September 5, 2025September 5, 2025 Shares of Zydus Lifesciences Ltd were trading 2% higher on 5 September after the company announced that its wholly-owned subsidiary, Zydus Lifesciences Global FZE, signed an exclusive licensing and supply deal with Synthon BV of the Netherlands for Ozanimod Capsules for the US market….
August 14, 2025August 14, 2025 Shares of Zydus Lifesciences Ltd are trading flat after touching a day’s high of Rs 1,002.85 on 14th August. This came after the company said the US Food and Drug Administration (USFDA) had concluded a surveillance inspection at its formulation manufacturing plant in Baddi,…
August 8, 2025August 8, 2025 Shares of Zydus Lifesciences Ltd opened in the green and 0.8% higher on 8 August after the company announced receiving a NOC from Health Canada for ZDS-Varenicline tablets 0.5 and 1 mg. In its regulatory filing, the company said, “Zydus Lifesciences has received NOC…
Shares of Zydus Lifesciences Ltd were trading in the red and 1% lower on 2 June after they announced securing tentative approval from the US Food and Drug Administration (USFDA) for Rifaximin tablets, 550 mg. Zydus Life stated that the tablets are approved for the treatment of irritable bowel syndrome with diarrhoea in adults. The…
April 1, 2025April 1, 2025 India’s pharmaceutical industry is on the rise, with its top companies becoming key players on the global stage. Behind their success lies a blend of innovation, cutting-edge research, and a drive to improve healthcare worldwide—making them a force to be reckoned with. In this…
March 17, 2025March 17, 2025 Shares of Zydus Lifesciences Ltd rose 1.5% to touch a day’s high of Rs 901.30 on 17th March after the firm announced that it had received final approval from the US Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets,…
February 14, 2025February 14, 2025 Zydus Lifesciences Ltd announced on Friday that the United States Food and Drug Administration (USFDA) has successfully completed an inspection of its Ahmedabad facility without any observations. The US health regulator inspected the company’s Topical Manufacturing site in Changodar, Ahmedabad, as part of a…